跳至主要内容
临床试验/NCT06230653
NCT06230653尚未招募不适用

A Single-centre, Randomised, Prospective Agreement Study to Determine the Clinical Performance and Safety of a Best Practice Medical Device With a Novel Sensor

University Hospital Ulm0 个研究点目标入组 40 人开始时间: 2024年1月22日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
主要终点
Precision of the Mechanomyography

研究概览

简要总结

Neuromuscular monitoring is used to evaluate neuromuscular function intraoperatively and to ensure complete neuromuscular recovery at the end of anaesthesia. Therefore, the lack of reliable neuromuscular monitoring devices that are not cumbersome to use is a major shortcoming for anaesthesia. A recently developed mechanomyography (MMG) device may meet these partially unmet needs due to its measurement of the patient's contractile force instead of its surrogates (i.e., acceleration, velocity), including the response to physiologically relevant tetanic stimulation. However, it is unclear whether the reliability of the newly developed MMG device is similar to or better than the currently available gold standard of neuromuscular monitoring based on electromyography (EMG).

详细描述

The MEMORY trial is a randomized clinical agreement study which will prospectively enrol thirty ASA 1 or 2 patients ≥ 18 years scheduled for non-cardiac surgery requiring general anaesthesia and neuromuscular blockade for optimisation of surgical conditions. The patient's neuromuscular function is measured on one hand with MMG and the other hand with EMG in a randomised fashion. Additionally, randomisation will be stratified the domination of one hand.

In the MEMORY trial we will test the hypothesis, that a newly developed MMG sensor provides not less reliable measurements of neuromuscular function compared to EMG in adult patients. Reliability includes agreement, precision, and the absence of staircase phenomenon and idiosyncratic responses to train-of-four (TOF) stimulation. In addition, we will explore if measurement of tetanic fade will provide more precise information about complete neuromuscular recovery than the current standard of TOF ratio >0.9.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥ 18 years
  • scheduled for non-cardiac surgery requiring general anaesthesia and neuromuscular blockade for optimisation of surgical conditions
  • positioning during surgery with intraoperative access to both arms

排除标准

  • allergy to muscle relaxants and reversal agents
  • neuromuscular disease
  • procedure is scheduled outside the operating room
  • need of endotracheal intubation prior to surgery
  • need of rapid sequence induction
  • pregnancy, breastfeeding or 30 days postpartum
  • surgical procedure or examination findings which are a contraindication for a supraglottic airway device
  • employee of the investigator or study site directly involved in this study or other studies under the direction of the investigator or study site
  • family member of the investigator
  • custodial accommodation
  • alcohol or drug abuse
  • patients with preceding injuries impairing muscle or nerve function of the arm
  • Participation in other studies with investigational drugs or devices within 4 weeks prior to screening or missing agreement not to participate in any other study at the same time or within a period of one month after the MEMORY study

结局指标

主要结局

Precision of the Mechanomyography

时间窗: intraoperative

Measured by the repeatability coefficient at baseline and at complete neuromuscular recovery

次要结局

  • Confirmation of handling and precision of Mechanomyography sensor(intraoperative)
  • Agreement of the TOF ratio between Electromyography and Mechanomyography(intraoperative)

研究者

发起方
University Hospital Ulm
申办方类型
Other
责任方
Principal Investigator
主要研究者

Manfred Blobner

Principal Investigator

University Hospital Ulm

相似试验